Cidara Therapeutics snags $42 mln Series B
San Diego-based biotech firm Cidara Therapeutics Inc has closed $42 million in Series B funding. The investors in this round were not named; however, the firm's previous backers include 5AM Ventures, Aisling Capital, Frazier Healthcare and InterWest Partners.
12 February 2015•2 mins read
